HUMIRA &GO Trademark

Trademark Overview

On Tuesday, March 21, 2017, a trademark application was filed for HUMIRA &GO with the United States Patent and Trademark Office. The USPTO has given the HUMIRA &GO trademark a serial number of 87379037. The federal status of this trademark filing is REGISTERED as of Tuesday, November 20, 2018. This trademark is owned by AbbVie Biotechnology Ltd.. The HUMIRA &GO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

providing medical information, namely, information regarding medical conditions, treatments and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment
humira &go

General Information

Serial Number87379037
Word MarkHUMIRA &GO
Filing DateTuesday, March 21, 2017
Status700 - REGISTERED
Status DateTuesday, November 20, 2018
Registration Number5612676
Registration DateTuesday, November 20, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements

Pseudo MarkHUMIRA AND GO
Goods and Servicesproviding medical information, namely, information regarding medical conditions, treatments and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 24, 2017
Primary Code044
First Use Anywhere DateThursday, June 22, 2017
First Use In Commerce DateThursday, June 22, 2017

Trademark Owner History

Party NameAbbVie Biotechnology Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM
Party NameAbbVie Biotechnology Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Monday, November 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 20, 2018REGISTERED-PRINCIPAL REGISTER
Friday, October 19, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 18, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 17, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 16, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 16, 2018SU - NON-FINAL ACTION - WRITTEN
Tuesday, October 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 3, 2018NON-FINAL ACTION E-MAILED
Tuesday, April 3, 2018SU - NON-FINAL ACTION - WRITTEN
Monday, March 12, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 20, 2018USE AMENDMENT FILED
Thursday, March 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 20, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 27, 2017ASSIGNED TO EXAMINER
Saturday, March 25, 2017NOTICE OF PSEUDO MARK E-MAILED
Friday, March 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 24, 2017NEW APPLICATION ENTERED

Related Keywords

humira medical healthcare professionals providing conditions information regarding namely treatment consultation